Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 72162-1856

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72162-1856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621856)

Each film-coated tablet contains 23.75 mg of metoprolol succinate, equivalent to 25 mg of metoprolol tartrate. It is essential to keep this medication out of the reach of children. The tablets should be stored within the temperature range of 15° to 30°C (59° to 86°F). Verify the product before dispensing to the patient. For more information, you can visit the provided link for inserts.*

FDA Label Image

Metoprolol-structure (Metoprolol Structure)

FDA Label Image

Metoprolol-table1a (Metoprolol Table1a)

The text provides results for subgroups in the MERIT-HF study regarding total mortality, all-cause hospitalization, and heart failure outcomes among patients treated with Metoprolol Succinate Extended-Release tablets compared to Placebo. The data is divided by various subgroups such as NYHA class, ejection fraction, etiology, gender, race, and comorbidities like diabetes mellitus and hypertension. The text also includes information on heart rate and definitions of abbreviations used such as NYHA, EF, MI, and HR. This data can be used to analyze the effectiveness of Metoprolol Succinate in different patient populations and clinical conditions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.